More than 90% of CMT patients have mutations in the peripheral myelin protein 22 (PMP22), myelin protein zero (MPZ), mitofusin 2 gene (MFN2), or gap junction protein beta 1 (GJB1) genes [87]. Here, PMP22 is linked to Charcot-Marie-Tooth disease.